Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

85.60 -2.18 (-2.48%)
Streaming Delayed Price Updated: 2:12 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about LeMaitre Vascular, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find Risky
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
3 Small-Cap Stocks We Keep Off Our Radar
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,... 
Via StockStory
News headline image
1 Cash-Producing Stock with Solid Fundamentals and 2 We Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
3 Profitable Stocks That Concern Us
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
Reflecting On Surgical Equipment & Consumables - Specialty Stocks’ Q3 Earnings: LeMaitre (NASDAQ:LMAT)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
LeMaitre Vascular Inc (NASDAQ:LMAT) Embodies Quality Investing Principles ↗
LeMaitre Vascular exemplifies quality investing with strong revenue growth, exceptional capital returns, and a debt-light balance sheet. 
Via Chartmill
News headline image
1 Small-Cap Stock to Target This Week and 2 That Underwhelm
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Question
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
News headline image
1 Reason LMAT is Risky and 1 Stock to Buy Instead
LeMaitre currently trades at $83.37 per share and has shown little upside over the past six months, posting a middling return of 2.9%. The stock also fell short of the S&P 500’s 15.6% gain during that... 
Via StockStory
Topics Stocks Supply Chain
News headline image
LeMaitre (LMAT) Q3 2025 Earnings Call Transcript ↗
LeMaitre (LMAT) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
3 Healthcare Stocks We Steer Clear Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but... 
Via StockStory
Topics Stocks
News headline image
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 
Via StockStory
Topics Economy
News headline image
LeMaitre Vascular Inc (NASDAQ:LMAT) Stands Out as a Quality Investment Using the Caviar Cruise Screen ↗
LeMaitre Vascular (LMAT) is a high-quality medical device company with strong revenue & EBIT growth, a 32.83% ROIC, and a solid financial profile. 
Via Chartmill
News headline image
3 Russell 2000 Stocks Walking a Fine Line
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
5 Must-Read Analyst Questions From LeMaitre’s Q3 Earnings Call
LeMaitre’s third quarter results drew a negative market reaction as revenue trailed Wall Street expectations, despite solid year-over-year growth. Management cited strong performances from the Grafts... 
Via StockStory
Topics Earnings
News headline image
LMAT Q3 Deep Dive: Pricing and Margin Expansion Offset by Cautious Growth Outlook
Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 11.4% year on year to $61.05 million. Next quarter’s revenue guidance of... 
Via StockStory
News headline image
LeMaitre (NASDAQ:LMAT) Reports Sales Below Analyst Estimates In Q3 Earnings
Medical device company LeMaitre Vascular (NASDAQ:LMAT) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 11.4% year on year to $61.05 million. Next quarter’s revenue guidance... 
Via StockStory
News headline image
LeMaitre Earnings: What To Look For From LMAT
Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results this Thursday after the bell. Here’s what investors should know. 
Via StockStory
News headline image
3 Cash-Producing Stocks We Think Twice About
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
Where LeMaitre Vascular Stands With Analysts ↗
 
Via Benzinga
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
News headline image
Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: LeMaitre (NASDAQ:LMAT) Shines
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including LeMaitre (NASDAQ:LMAT) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 High-Flying Stock with Solid Fundamentals and 2 We Ignore
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly... 
Via StockStory
News headline image
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a... 
Via MarketMinute
Topics Government
News headline image
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing... 
Via MarketMinute
Topics Economy Government World Trade
News headline image
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. 
Via StockStory
Topics Government
News headline image
3 Reasons LMAT is Risky and 1 Stock to Buy Instead
Since March 2025, LeMaitre has been in a holding pattern, posting a small return of 1.8% while floating around $85.45. The stock also fell short of the S&P 500’s 18.6% gain during that period. 
Via StockStory
Topics Stocks Supply Chain
News headline image
Integra LifeSciences and LeMaitre Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.